Price Alert

Avanos Medical Inc. (AVNS)

NYSE: AVNS · Real-Time Price · USD

11.20

0.24 (2.19%)

At close: Aug 15, 2025, 3:59 PM

11.22

0.22%

After-hours: Aug 15, 2025, 06:00 PM EDT

Avanos Medical Statistics

Share Statistics

Avanos Medical has 46.4M shares outstanding. The number of shares has increased by 0.64% in one year.

Shares Outstanding	46.4M
Shares Change (YoY)	0.64%
Shares Change (QoQ)	0.52%
Owned by Institutions (%)	94.08%
Shares Floating	44.91M
Failed to Deliver (FTD) Shares	58
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 1.51M, so 3.28% of the outstanding shares have been sold short.

Short Interest	1.51M
Short % of Shares Out	3.28%
Short % of Float	4.66%
Short Ratio (days to cover)	3.9

Valuation Ratios

The PE ratio is -1.87 and the forward PE ratio is 9.8. Avanos Medical's PEG ratio is 0.

PE Ratio	-1.87
Forward PE	9.8
PS Ratio	1.06
Forward PS	0.7
PB Ratio	0.88
P/FCF Ratio	8.83
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Avanos Medical.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.21.

Current Ratio	2.37
Quick Ratio	1.53
Debt / Equity	0.21
Debt / EBITDA	-0.49
Debt / FCF	2.05
Interest Coverage	-32.48

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$308.85K
Profits Per Employee	$-176.07K
Employee Count	2,227
Asset Turnover	0.6
Inventory Turnover	2.21

Taxes

Income Tax	-17M
Effective Tax Rate	4.22%

Stock Price Statistics

The stock price has increased by -52.97% in the last 52 weeks. The beta is 1.12, so Avanos Medical's price volatility has been higher than the market average.

Beta	1.12
52-Week Price Change	-52.97%
50-Day Moving Average	11.94
200-Day Moving Average	14.94
Relative Strength Index (RSI)	41.84
Average Volume (20 Days)	489,190

Income Statement

In the last 12 months, Avanos Medical had revenue of 687.8M and earned -392.1M in profits. Earnings per share was -8.53.

Revenue	687.8M
Gross Profit	381.3M
Operating Income	-396.2M
Net Income	-392.1M
EBITDA	-345.6M
EBIT	-391.1M
Earnings Per Share (EPS)	-8.53

Full Income Statement

Balance Sheet

The company has 107.7M in cash and 170.2M in debt, giving a net cash position of -62.5M.

Cash & Cash Equivalents	107.7M
Total Debt	170.2M
Net Cash	-62.5M
Retained Earnings	-707M
Total Assets	1.04B
Working Capital	221.4M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 100.7M and capital expenditures -17.8M, giving a free cash flow of 82.9M.

Operating Cash Flow	100.7M
Capital Expenditures	-17.8M
Free Cash Flow	82.9M
FCF Per Share	1.8

Full Cash Flow Statement

Margins

Gross margin is 55.44%, with operating and profit margins of -57.6% and -57.01%.

Gross Margin	55.44%
Operating Margin	-57.6%
Pretax Margin	-58.64%
Profit Margin	-57.01%
EBITDA Margin	-50.25%
EBIT Margin	-57.6%
FCF Margin	12.05%

Dividends & Yields

AVNS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for AVNS.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-0.51
Piotroski F-Score	5